Wang, Xiao-Kun <br/><br/>
Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo.  [electronic resource] 

 -  Oncotarget  Dec 2014 
 - 11971-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--antagonists & inhibitors<br/>Afatinib<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Immunohistochemistry<br/>In Vitro Techniques<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Neoplasms, Experimental--drug therapy<br/>Quinazolines--pharmacology<br/>Real-Time Polymerase Chain Reaction<br/>Topotecan--pharmacology<br/>Xenograft Model Antitumor Assays